Patent · US Expired

Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia

US7018371B2 · kind B2 · utility

18Cited by
89References
32Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 7, 2001
Grant dateMar 28, 2006
Priority date
Expiry dateApr 17, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/1004
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides improved devices, methods, and kits for inhibiting restenosis and hyperplasia after intravascular intervention. In particular, the present invention provides controlled radiosensitizer delivery in combination with ionizing radiation to selected locations within a patient's vasculature to reduce and/or inhibit restenosis and hyperplasia rates with increased efficacy. In one embodiment, the combination radiation and radiosensitizer delivery catheter for inhibiting hyperplasia comprises a catheter body having a proximal end and distal end, an ionizing radiation source coupleable to the catheter body for applying a radiation dose to a body lumen, and a porous material, matrix, membrane, banier, coating, infusion lumen, stent, graft, or reservoir for releasing an radiosensitizer to the body lumen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.